Inogen : Management Change/Compensation - Form 8-K
November 27, 2023 at 04:03 pm EST
Share
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Nabil Shabshab Separation Agreement; Resignation as a Director
As previously announced in the Current Report on Form 8-K filed by Inogen, Inc. (the "Company"), dated November 10, 2023, Mr. Shabshab's role as an officer and employee of the Company ended effective November 10, 2023 (the "Separation Date"). In connection with the separation of Mr. Shabshab's employment with the Company, on November 22, 2023, Mr. Shabshab and the Company entered into a separation agreement and release related to the termination of Mr. Shabshab's employment with the Company (the "Separation Agreement").
The Separation Agreement provides that, subject to (a) Mr. Shabshab's execution of the Separation Agreement, (b) the Separation Agreement becoming effective, and (c) Mr. Shabshab's continued compliance with the terms of the Separation Agreement, the Company will provide Mr. Shabshab with the severance benefits set forth in Mr. Shabshab's Employment and Severance Agreement with the Company, dated January 22, 2021.
Also in connection with the separation of his employment with the Company and the entry into the Separation Agreement, Mr. Shabshab resigned from the Company's board of directors, effective as of November 22, 2023. Mr. Shabshab's resignation is not the result of any disagreement with the Company relating to the Company's operations, policies or practices.
The summary of the Separation Agreement set forth above does not purport to be complete and is qualified in its entirety by reference to the full text of the Separation Agreement, which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated by reference herein.
Inogen Inc. published this content on 27 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 November 2023 21:02:34 UTC.
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
INOGEN, INC. 
